Newsroom
Filters: Biosimilar medicines
x
Biosimilar medicines are a part of today’s therapeutic armamentarium – […]
Read moreWith 10 years of positive experience with biosimilar medicines, medical […]
Read moreKey authorities, eminent lawyers and industry leaders discussed today in […]
Read moreUS FDA interchangeability guidance adds another level of confusion over […]
Read moreOn 9th March, IFPMA launched jointly with EFPIA and EBE […]
Read moreMedicines for Europe welcomes the fact that EFPIA (supported by […]
Read moreToday, the European Parliament voted on the report on ‘Options […]
Read moreEurope is the cradle of the manufacturing industry and has […]
Read moreMedicines for Europe welcomes the approval by the European Parliament […]
Read more